APA (7th ed.) Citation

Wang, Z., Zhang, R., Cao, Y., Chen, Y., Huang, S., & Luo, Y. (2023). Investigation of the efficacy and feasibility of combined therapy of PD‐L1‐enhanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy in the treatment of extensive‐stage small cell lung cancer. Wiley.

Chicago Style (17th ed.) Citation

Wang, Zhizhen, Ruiping Zhang, Yuchan Cao, Yang Chen, Sheng Huang, and Yan'an Luo. Investigation of the Efficacy and Feasibility of Combined Therapy of PD‐L1‐enhanced Exogenous Peripatetic Adoptive Natural Killer (NK) Cells in Combination with Antiangiogenic Targeted Therapy in the Treatment of Extensive‐stage Small Cell Lung Cancer. Wiley, 2023.

MLA (9th ed.) Citation

Wang, Zhizhen, et al. Investigation of the Efficacy and Feasibility of Combined Therapy of PD‐L1‐enhanced Exogenous Peripatetic Adoptive Natural Killer (NK) Cells in Combination with Antiangiogenic Targeted Therapy in the Treatment of Extensive‐stage Small Cell Lung Cancer. Wiley, 2023.